Full Text View
Tabular View
No Study Results Posted
Related Studies
Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg
This study has been completed.
Study NCT00649714   Information provided by Mylan Pharmaceuticals
First Received: March 30, 2008   Last Updated: March 31, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Zonisamide Capsules 100 mg
Zonegran® Capsules 100 mg
Additional drug interventions recognized in this trial
Zonisamide
More general drug interventions related to this trial
Anticonvulsants
Antioxidants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Mylan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services